ESGO 2021 | Novel immunotherapy-based combination approaches in cervical cancer

Name: Novel immunotherapy-based combination approaches in cervical cancer
Uploaded: 2021-10-23T00:00:00Z
Duration: 1 min 19 s
Description: Alexandra Leary, MD, PhD, Gustave Roussy Institute, Villejuif, France, explores immunotherapy-based combination approaches in cervical cancer, including combining immunotherapy with chemotherapy, angiogenesis inhibitors as well as therapeutic vaccines. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.

Alexandra Leary • 23 Oct 2021

ESGO 2021

Gynecological Cancer Ovarian Cancer

Alexandra Leary, MD, PhD, Gustave Roussy Institute, Villejuif, France, explores immunotherapy-based combination approaches in cervical cancer, including combining immunotherapy with chemotherapy, angiogenesis inhibitors as well as therapeutic vaccines. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.